The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Danon’s disease as a cause of hypertrophic cardiomyopathy: a systematic survey
Open accessAbstract
Background: Hypertrophic cardiomyopathy (HCM) is an autosomal dominant disease caused by mutations in sarcomeric genes. However, extensive genetic screening failed to identify a mutation in about a third of cases. One possible explanation is that other diseases, caused by other genes, may mimic HCM. Objective: To investigate the possible involvement of Danon’s disease, an X linked lysosomal disease, in a large population of patients with HCM. Methods: A population of 197 index cases was considered; 124 were subsequently excluded because of a mutation in sarcomeric genes and 23 because of autosomal dominant inheritance. Fifty index cases were therefore included in molecular analysis (direct sequencing) of the lysosome associated membrane protein 2 (LAMP2) gene responsible for Danon’s disease. Results: Two new mutations leading to premature stop codons were identified in patients who evolved towards severe heart failure (< 25 years old): 657C>T and 173_179del. The prevalence was therefore 1% of the total population (two of 197) or 4% of enrolled index cases (two of 50). Interestingly, Danon’s disease was responsible for half of the cases (two of four) with HCM and clinical skeletal myopathy but was not involved in isolated HCM (none of 41). Conclusions: Danon’s disease may be involved in patients with previously diagnosed as HCM. A diagnosis strategy is proposed. To distinguish HCM from Danon’s disease is important because the clinical evolution, prognosis, mode of inheritance, and therefore genetic counselling are very different.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hypertrophic Cardiomyopathy: A Systematic Review
Maron, B. J. (2002) · JAMA · doi:10.1001/jama.287.10.1308 · Cited by 2,224
Cited by
2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy
Authors/Task Force members, Elliott, P. M., Anastasakis, A., Borger, M. A., Borggrefe, M., Cecchi, F., Charron, P., Hagege, A. A., Lafont, A., Limongelli, G., et al. (2014) · European Heart Journal · doi:10.1093/eurheartj/ehu284 · Cited by 4,332
Self-citationMetabolic control of cell death
Green, D. R., Galluzzi, L., & Kroemer, G. (2014) · Science · doi:10.1126/science.1250256 · Cited by 647
Pastores, G. M. (2012) · Swaiman's Pediatric Neurology · doi:10.1016/b978-1-4377-0435-8.00036-6 · Cited by 633
Colan, S. D., Lipshultz, S. E., Lowe, A. M., Sleeper, L. A., Messere, J., Cox, G. F., Lurie, P. R., Orav, E. J., & Towbin, J. A. (2007) · Circulation · doi:10.1161/circulationaha.106.621185 · Cited by 474
Rapezzi, C., Arbustini, E., Caforio, A. L. P., Charron, P., Gimeno-Blanes, J., Helio, T., Linhart, A., Mogensen, J., Pinto, Y., Ristic, A., et al. (2013) · European Heart Journal · doi:10.1093/eurheartj/ehs397 · Cited by 439
Self-citation
Metadata
- Authors
- Charron, P., Villard, E., Sébillon, P., Laforêt, P., Maisonobe, T., Duboscq-Bidot, L., Romero, N., Drouin-Garraud, V, Frébourg, T., Richard, P., Eymard, B., & Komajda, M.
- Venue
- Heart
- Publisher
- BMJ
- Published
- 2004-07-14
- Volume
- 90
- Issue
- 8
- Pages
- 842-846
- ISSN
- 1355-6037 (ISSN-L)
- 1468-201X
- OpenAlex
- W2118418827
- Cited by
- 172
- References
- 1
- FWCI
- 3.30
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Danon’s disease as a cause of hypertrophic cardiomyopathy: a systematic survey. https://app.cochat.ai/papers/10.1136/hrt.2003.029504
- The paper
- Charron, P., Villard, E., Sébillon, P., Laforêt, P., Maisonobe, T., Duboscq-Bidot, L., Romero, N., Drouin-Garraud, V, Frébourg, T., Richard, P., Eymard, B., & Komajda, M. (2004). Danon’s disease as a cause of hypertrophic cardiomyopathy: a systematic survey. Heart. https://doi.org/10.1136/hrt.2003.029504
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.